Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations
- PMID: 18689547
- DOI: 10.1182/blood-2008-04-152967
Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations
Abstract
Down syndrome (DS) children have a high frequency of acute megakaryoblastic leukemia (AMKL) in early childhood. At least 2 in utero genetic events are required, although not sufficient, for DS-AMKL: trisomy 21 (T21) and N-terminal-truncating GATA1 mutations. To investigate the role of T21 in DS-AMKL, we compared second trimester hemopoiesis in DS without GATA1 mutations to gestation-matched normal controls. In all DS fetal livers (FLs), but not marrows, megakaryocyte-erythroid progenitor frequency was increased (55.9% +/- 4% vs 17.1% +/- 3%, CD34(+)CD38(+) cells; P < .001) with common myeloid progenitors (19.6% +/- 2% vs 44.0% +/- 7%) and granulocyte-monocyte (GM) progenitors (15.8% +/- 4% vs 34.5% +/- 9%) commensurately reduced. Clonogenicity of DS-FL versus normal FL CD34(+) cells was markedly increased (78% +/- 7% vs 15% +/- 3%) affecting megakaryocyte-erythroid ( approximately 7-fold higher) and GM and colony-forming unit-granulocyte, erythrocyte macrophage, megakaryocyte (CFU-GEMM) progenitors. Replating efficiency of CFU-GEMM was also markedly increased. These data indicate that T21 itself profoundly disturbs FL hemopoiesis and they provide a testable hypothesis to explain the increased susceptibility to GATA1 mutations in DS-AMKL and DS-associated transient myeloproliferative disorder.
Similar articles
-
Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.Blood Cells Mol Dis. 2003 Nov-Dec;31(3):351-6. doi: 10.1016/j.bcmd.2003.08.001. Blood Cells Mol Dis. 2003. PMID: 14636651
-
Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis.Early Hum Dev. 2006 Dec;82(12):767-73. doi: 10.1016/j.earlhumdev.2006.09.016. Epub 2006 Oct 24. Early Hum Dev. 2006. PMID: 17064858 Review.
-
Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.Blood. 2003 Aug 1;102(3):981-6. doi: 10.1182/blood-2002-11-3599. Epub 2003 Mar 20. Blood. 2003. PMID: 12649131
-
Natural history of GATA1 mutations in Down syndrome.Blood. 2004 Apr 1;103(7):2480-9. doi: 10.1182/blood-2003-10-3383. Epub 2003 Dec 4. Blood. 2004. PMID: 14656875
-
Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.Br J Haematol. 2009 Oct;147(1):3-12. doi: 10.1111/j.1365-2141.2009.07789.x. Epub 2009 Jul 6. Br J Haematol. 2009. PMID: 19594743 Review.
Cited by
-
Differentiated Cells Derived from Hematopoietic Stem Cells and Their Applications in Translational Medicine.Adv Exp Med Biol. 2021;1347:29-43. doi: 10.1007/5584_2021_644. Adv Exp Med Biol. 2021. PMID: 34114129
-
The biology of pediatric acute megakaryoblastic leukemia.Blood. 2015 Aug 20;126(8):943-9. doi: 10.1182/blood-2015-05-567859. Epub 2015 Jul 17. Blood. 2015. PMID: 26186939 Free PMC article. Review.
-
Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.J Mol Diagn. 2009 Sep;11(5):371-80. doi: 10.2353/jmoldx.2009.080132. J Mol Diagn. 2009. PMID: 19710397 Free PMC article. Review.
-
The impact of trisomy 21 on foetal haematopoiesis.Blood Cells Mol Dis. 2013 Dec;51(4):277-81. doi: 10.1016/j.bcmd.2013.07.008. Epub 2013 Aug 7. Blood Cells Mol Dis. 2013. PMID: 23932236 Free PMC article. Review.
-
GATA1 in Normal and Pathologic Megakaryopoiesis and Platelet Development.Adv Exp Med Biol. 2024;1459:261-287. doi: 10.1007/978-3-031-62731-6_12. Adv Exp Med Biol. 2024. PMID: 39017848 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials